These findings highlight the potential of RNF213 as both a biomarker and therapeutic target for intracranial artery stenosis and stroke, underscoring the need for more in-depth and comprehensive understanding of its role in cerebrovascular pathology. This evidence concerns the gene RNF213 and Stroke.